KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Total Current Liabilities (2020 - 2026)

AbCellera Biologics filings provide 7 years of Total Current Liabilities readings, the most recent being $47.3 million for Q1 2026.

  • Quarterly Total Current Liabilities fell 37.27% to $47.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $47.3 million through Mar 2026, down 37.27% year-over-year, with the annual reading at $64.3 million for FY2025, 16.06% down from the prior year.
  • Total Current Liabilities hit $47.3 million in Q1 2026 for AbCellera Biologics, down from $64.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $221.1 million in Q2 2022 and bottomed at $47.3 million in Q1 2026.
  • Average Total Current Liabilities over 5 years is $103.0 million, with a median of $89.6 million recorded in 2023.
  • The largest annual shift saw Total Current Liabilities soared 217.01% in 2022 before it crashed 58.02% in 2023.
  • AbCellera Biologics' Total Current Liabilities stood at $118.3 million in 2022, then rose by 0.59% to $119.0 million in 2023, then plummeted by 35.63% to $76.6 million in 2024, then dropped by 16.06% to $64.3 million in 2025, then decreased by 26.46% to $47.3 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Total Current Liabilities are $47.3 million (Q1 2026), $64.3 million (Q4 2025), and $68.8 million (Q3 2025).